Loading...

An Introduction to Infraslow Neurofeedback (ISF-NF): theoretical foundation, research overview and clinical insights

About

Tanya Morosoli, MSc, BCN fellow

1-day workshop
Date: April 10, 2024

Workshop Title

An Introduction to Infraslow Neurofeedback (ISF-NF): theoretical foundation, research overview and clinical insights

Workshop Description

Neurofeedback as a therapeutic intervention that involves a brain computer interface allowing to monitor and modulate real-time electroencephalographic (EEG) parameters has been practiced for over six decades. Since then, software and hardware developments, allowed to explore alternative clinically driven methodologies, expanding the number of neurofeedback training modalities associated with variable levels of scientific evidence. Among these more recent approaches, Infra-Slow Frequency Neurofeedback (ISF NF) was developed as a combined result of clinical observations and the availability of DC-coupled amplifiers. This method consists of providing a real-time feedback based on infra-slow fluctuations (below 1Hz) while being able to adjust the trained frequency according to psychophysiological changes during and after sessions, to optimize it. Since its early development, this neurofeedback modality has evolved into two subtypes: ISF bipolar and ISF sLORETA, and although mechanisms of action underlying clinical outcomes remain largely unknown, growing evidence is gradually supporting its efficacy and contributing to the understanding of the involved regulatory processes within the nervous system. This workshop will introduce the theoretical foundations of ISF NF, provide an overview of the clinical research, and illustrate the therapeutic process through clinical cases. In addition, a hands-on experience will be provided to further clarify the specificities of this methodology.

Learning Objectives

1) Differentiate ISF-Neurofeedback (ISF-NF) from other Neurofeedback modalities, theoretically and practically.

2) Understand the clinical and theoretical foundations of ISF-NF.

3) Familiarize with the ISF-NF research through a critical review of clinical studies.

About Tanya Morosoli

Dr. Morosoli is a Neuropsychologist who obtained her Degree in Psychology from the University of Geneva, Switzerland, a Master’s Degree in Neuroscience from Barcelona University, Spain and a Master’s Degree in Clinical Neuropsychology from the European University Miguel de Cervantes.

She completed a postgraduate program on Principles and Practice of Clinical Research (PPCR), from Harvard Medical School in 2013 and was invited to collaborate as Teaching Assistant (TA) and Senior TA for 5 years in this Clinical Research educational program, currently offered by Harvard School of Public Health. She was Mexico City Site Director of this course (2019-2021).

Founder and Director of a Neuropsychology Clinic in Mexico, she leads a multidisciplinary team which provides comprehensive assessment and treatment. She currently also has a practice in Switzerland where she is accredited by Swiss health insurances. She was trained in QEEG by Barry Sterman, has used neurofeedback for the past 20 years and has been BCIA Certified in Neurofeedback since 2008. She is part of the faculty who teaches the Neurofeedback BCIA didactic course in Spanish, a Neurofeedback postgraduate university course offered by the University of La Salle and the Mexican Society for Bio and Neurofeedback, and teaches modules for French and Swiss Bio & Neurofeedback courses. She has provided mentoring towards BCIA certification and for the development of research protocols in Neurofeedback.

She was founder member and Past President of the Mexican Society for Bio and Neurofeedback. She is founder and board member of the Biofeedback Certificate International Alliance-Hispanoamerica (BCIA-H) and has served on ISNR board for more than four years, currently serving as its President. In 2021, she was awarded the ISNR Presidential Award of Merit and the The Joseph and Ann Marie Horvat Distinguished Service Award for accomplishing international collaboration. She is associate editor for Neuroregulation.